ALNEV — Neovacs SA Income Statement
0.000.00%
Last trade - 00:00- €0.01m
- €0.14m
- €0.29m
- 9
- 100
- 10
- 29
Annual income statement for Neovacs SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | — | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.03 | 0.023 | 0.001 | 0.533 | 0.291 |
| Cost of Revenue | |||||
| Gross Profit | -0.09 | -0.462 | -0.576 | 0.029 | -0.033 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4.59 | 10.6 | 7.47 | 8.01 | 7.37 |
| Operating Profit | -4.56 | -10.6 | -7.47 | -7.47 | -7.08 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.68 | -12.5 | -4.35 | -9.62 | -33.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.14 | -11.8 | -3.55 | -8.74 | -32.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.14 | -11.8 | -3.55 | -8.74 | -32.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.14 | -11.8 | -3.55 | -8.74 | -32.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | — | — | — | -238,135,577 | -186,894 |
| Dividends per Share |